Skip to main content
. 2020 Mar 12;11:94. doi: 10.3389/fpsyt.2020.00094

Table 4.

Tricyclic antidepressants dosing advice based on CYP2C19 and CYP2D6 phenotype according to DPWG and/or CPIC; see (78).

TCAs CYP2C19 CYP2D6
Poor metabolizer Intermediate metabolizer Normal metabolizer Ultrarapid metabolizer Poor metabolizer Intermediate metabolizer Normal metabolizer Ultrarapid metabolizer
Amitriptyline Nortriptyline/
desimpramine or 50% dose reduction
Recommended starting dose Recommended starting dose Nortriptyline/
desimpramine or 50% dose increase
No TCA or 50% Reduce dose by 25% Recommended starting dose No TCA or higher dose
Clomipramine Nortriptyline/
desimpramine or 50%
Recommended starting dose Recommended starting dose Nortriptyline/
desimpramine or 50% dose increase
No TCA or 50% dose reduction Reduce dose by 25% Recommended starting dose No TCA or higher dose
Doxepine Nortriptyline/
desimpramine or 50%
Recommended starting dose Recommended starting dose Nortriptyline/
desimpramine or 50%
Reduce dose by 60% Reduce dose by 20% Recommended starting dose No TCA or 100% higher dose
Imipramine Nortriptyline/
desimpramine or 50%
Recommended starting dose Recommended starting dose Nortriptyline/
desimpramine or 50%
No TCA or 70% dose reduction No TCA or 30% dose reduction Recommended starting dose No TCA or 70% dose increase
Nortriptyline Recommended starting dose Recommended starting dose 100% No TCA or 60% dose reduction No TCA or 40% dose reduction Recommended starting dose No TCA or 60% dose increase